Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. - Wikidata - wikimedia - TriplyDB

Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival.

Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival.

http://www.wikidata.org/entity/Q34952301

about

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine

P2860

Q26796247-5EF4A5EA-5EBE-446B-8D9E-39DCA2BFFEB8

P2860

Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival.

http://www.wikidata.org/entity/Q34952301

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Syndecan-1 is a potential biom ...... with correlation to survival.

@ast

Syndecan-1 is a potential biom ...... with correlation to survival.

@en

Syndecan-1 is a potential biom ...... with correlation to survival.

@nl

type

label

Syndecan-1 is a potential biom ...... with correlation to survival.

@ast

Syndecan-1 is a potential biom ...... with correlation to survival.

@en

Syndecan-1 is a potential biom ...... with correlation to survival.

@nl

prefLabel

Syndecan-1 is a potential biom ...... with correlation to survival.

@ast

Syndecan-1 is a potential biom ...... with correlation to survival.

@en

Syndecan-1 is a potential biom ...... with correlation to survival.

@nl

P1433

Q34952301-4A5EA965-A1EA-40B6-BB2D-A97AE028E02C

P1476

Q34952301-B13623B9-3D15-4E05-B81E-1EA62A6B3895

P2093

Q34952301-0F26ADA3-DE02-4179-8303-EF1605B070C6

Q34952301-35FB6A69-7124-4D42-BB70-28F4EBC7737C

Q34952301-65F9A488-8984-4759-847B-60E1983D9F41

Q34952301-895F9BBB-AEA6-44E4-BB63-7839742C739D

Q34952301-C90A0B42-306D-4764-A5FA-716697D7AFD6

Q34952301-D48E75FD-24E0-423A-9499-3CBBB51F53CA

P2860

Q34952301-04184853-3B63-434F-BE52-F14A1D90A94C

Q34952301-0E1D9884-ECE5-4F2A-84E8-9CA64EF7381B

Q34952301-45D621D0-E41B-4954-90EB-C7B7A6E88AFF

Q34952301-4B6D3995-EA47-4A05-8E74-6C36F44652CB

Q34952301-5686FE93-6EEB-43EB-9C8D-81114B2607B6

Q34952301-66497E0A-0301-40FC-9CED-C8C5335FEA11

Q34952301-67DD8AC4-4550-4CA3-A04F-7D96B9C95FFD

Q34952301-6D4582FD-E8F0-408D-A4DB-F72CBBC6B4D4

Q34952301-7FDA0AD7-790A-4487-9FB9-007F557AD9FC

Q34952301-8CFE94BC-4646-405B-A563-6702C0B0E5F2

P304

Q34952301-3571F421-38A2-4D5D-89CC-FC12D146DE77

P31

Q34952301-21238C95-030B-435C-A2FE-49C3676229DD

P356

Q34952301-DF5053E6-D379-4EB6-A876-BBF841D089DE

P433

Q34952301-036E4E3E-264E-46E9-8DC2-A63BACC43F08

P478

Q34952301-F711C9DB-2D4A-46DA-AE84-D7668B381B7F

P50

Q34952301-B1D79A10-2599-41C4-9FE4-69C99DCBDEC6

P577

Q34952301-91B3E790-676A-4B9E-9040-3A50A1E10C69

P698

Q34952301-0C24E508-5A5B-465C-8597-94769074BF4C

P921

Q34952301-A202F478-D147-4C33-B15F-672F0FB20B67

P932

Q34952301-8EEF3D51-EACE-4ECC-B8BA-FD93E829B606

P356

P1433

Singapore Medical Journal

P1476

Syndecan-1 is a potential biom ...... with correlation to survival.

@en

P2093

Ana Richelia Jara-Lazaro

http://www.w3.org/2001/XMLSchema#string

Aye Aye Thike

http://www.w3.org/2001/XMLSchema#string

George Wai-Cheong Yip

http://www.w3.org/2001/XMLSchema#string

Puay-Hoon Tan

http://www.w3.org/2001/XMLSchema#string

Von-Bing Yap

http://www.w3.org/2001/XMLSchema#string

Wey-Cheng Sim

http://www.w3.org/2001/XMLSchema#string

P2860

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ

Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002.

Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis

Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study.

Is breast cancer the same disease in Asian and Western countries?

Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility.

Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma

Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival.

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.

Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival.

P304

468-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.11622/SMEDJ.2014115

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25273930

http://www.w3.org/2001/XMLSchema#string

P921

P932

4293941

http://www.w3.org/2001/XMLSchema#string